DEF 14A Filing

Company

ADMA BIOLOGICS, INC.

Filed

April 24, 2019

Period of Report

June 5, 2019

Accession Number

0001193805-19-000415

A DEF 14A is a proxy statement sent to shareholders before an annual meeting. It covers executive compensation, board elections, and shareholder votes. Learn more about DEF 14A filings →